Edwards Lifesciences Corporation (EW)

NYSE: EW · Real-Time Price · USD

82.39

+1.01 (1.24%)

At close: May 18, 2026, 4:00 PM EDT

82.00

-0.39 (-0.47%)

After-hours: May 18, 2026, 7:45 PM EDT

Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,446	2,938	3,045	1,132	769	862.8
Short-Term Investments	1,226	1,288	930.7	500.5	446.3	604
Cash & Short-Term Investments	3,672	4,226	3,976	1,633	1,215	1,467
Cash Growth	-5.82%	6.30%	143.50%	34.35%	-17.15%	4.58%
Accounts Receivable	775.7	659.6	609.1	771.5	643	582.2
Other Receivables	197.3	252.5	118.3	56.6	56.1	82.7
Total Trade Receivables	973	912.1	727.4	828.1	699.1	664.9
Inventory	1,119	1,126	1,087	903.5	875.5	726.7
Other Current Assets	465.2	474.3	495.4	353.7	305.9	322.3
Total Current Assets	6,229	6,739	6,285	4,036	3,096	3,181
Net Property, Plant & Equipment	1,922	1,915	1,784	1,675	1,725	1,639
Other Intangible Assets	1,228	1,128	1,177	399.4	285.2	323.6
Goodwill	1,820	1,769	1,777	1,145	1,164	1,168
Long-Term Investments	285.6	278.6	307.9	583.9	1,239	1,834
Other Long-Term Assets	1,837	1,868	1,725	1,524	783.1	357.5
Total Assets	13,321	13,697	13,055	9,363	8,293	8,503
Accounts Payable	181.1	227.5	197.4	186.6	201.9	204.5
Accrued Expenses	1,204	1,562	1,282	856.4	795	802.3
Current Portion of Leases	24.3	24.5	23.4	22.9	25.5	25.5
Other Current Liabilities	-	-	2	129.5	-	-
Total Current Liabilities	1,409	1,814	1,505	1,195	1,022	1,032
Long-Term Debt	598.5	598.3	597.7	597	596.3	595.7
Long-Term Leases	80.1	82.6	78.9	65.2	69.5	69.1
Other Long-Term Liabilities	906.1	865	810.6	786.2	797.6	969.6
Total Long-Term Liabilities	1,585	1,546	1,487	1,448	1,463	1,634
Total Liabilities	2,994	3,360	2,992	2,644	2,486	2,667
Common Stock	660	658.7	654.8	650.5	646.3	642
Treasury Stock	-7,514	-7,092	-6,192	-5,025	-4,144	-2,417
Additional Paid-in Capital	2,782	2,768	2,613	2,274	1,969	1,700
Accumulated Other Comprehensive Income	-221.3	-238.3	-244.5	-242.8	-254.9	-157.7
Retained Earnings	14,621	14,241	13,167	8,992	7,590	6,068
Total Common Shareholders' Equity	10,328	10,338	9,998	6,650	5,807	5,836
Minority Interest	-	-	64.5	69.4	-	-
Shareholders' Equity	10,328	10,338	9,998	6,719	5,807	5,836
Total Liabilities & Equity	13,321	13,697	13,055	9,363	8,293	8,503
Total Debt	702.9	705.4	700	685.1	691.3	690.3
Net Cash (Debt)	2,969	3,521	3,276	947.7	524	776.5
Net Cash Growth	-15.69%	7.48%	245.67%	80.86%	-32.52%	9.72%
Net Cash Per Share	5.08	6.01	5.47	1.55	0.84	1.23
Book Value	10,328	10,338	9,998	6,650	5,807	5,836
Book Value Per Share	17.68	17.65	16.68	10.91	9.30	9.25
Tangible Book Value	7,280	7,441	7,045	5,106	4,357	4,344
Tangible Book Value Per Share	12.47	12.70	11.76	8.38	6.98	6.88

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q